Ketamine in Borderline Personality Disorder
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03395314 |
|
Recruitment Status :
Terminated
(assessment of project in wake of covid-19 related interruptions)
First Posted : January 10, 2018
Last Update Posted : June 1, 2022
|
Sponsor:
Yale University
Collaborators:
Nathan Kline Institute for Psychiatric Research
American Foundation for Suicide Prevention
Information provided by (Responsible Party):
Yale University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | May 6, 2022 |
| Actual Study Completion Date : | May 6, 2022 |